BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20736951)

  • 21. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
    Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells.
    Kim KC; Baek SH; Lee C
    Int J Oncol; 2015 Dec; 47(6):2296-303. PubMed ID: 26498137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo.
    Zhou H; Tang Y; Liang X; Yang X; Yang J; Zhu G; Zheng M; Zhang C
    Int J Cancer; 2009 Jul; 125(2):453-62. PubMed ID: 19391133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
    Huang H; Huang J; Yao J; Li N; Yang Z
    J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
    Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
    Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.
    Kenny HA; Leonhardt P; Ladanyi A; Yamada SD; Montag A; Im HK; Jagadeeswaran S; Shaw DE; Mazar AP; Lengyel E
    Clin Cancer Res; 2011 Feb; 17(3):459-71. PubMed ID: 21149615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
    Zhang H; Zhu X; Li N; Li D; Sha Z; Zheng X; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):496-503. PubMed ID: 25998575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.
    Morgillo F; Martinelli E; Troiani T; Laus G; Pepe S; Gridelli C; Ciardiello F
    Mol Cancer Ther; 2008 Jun; 7(6):1698-707. PubMed ID: 18566241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
    Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
    Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
    Liu XH; Lu KH; Wang KM; Sun M; Zhang EB; Yang JS; Yin DD; Liu ZL; Zhou J; Liu ZJ; De W; Wang ZX
    BMC Cancer; 2012 Aug; 12():348. PubMed ID: 22876840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
    Liao Y; Cao L; Wang F; Pang R
    J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer.
    Lee SH; Chen T; Zhou J; Hofmann J; Bepler G
    Clin Lung Cancer; 2010 May; 11(3):169-75. PubMed ID: 20439192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
    Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
    J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.